Lipella Pharmaceuticals公布Lp-10治疗口腔扁平苔藓2a期研究积极最终结果

美股速递09-18

Lipella Pharmaceuticals近日宣布，其针对口腔扁平苔藓治疗的候选药物Lp-10的2a期临床研究取得了积极的最终结果。

该项研究结果的公布标志着公司在开发这一创新疗法方面取得了重要进展。口腔扁平苔藓是一种慢性炎症性疾病，影响口腔黏膜，目前治疗选择有限。

Lp-10作为Lipella Pharmaceuticals的核心在研产品，此次2a期研究的成功为后续临床开发奠定了坚实基础。公司表示，这一积极结果将推动该候选药物向更大规模的临床试验阶段发展。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1124634041?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-18 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124634041","market":"us","top_or_hot":-1,"title":"Lipella Pharmaceuticals公布Lp-10治疗口腔扁平苔藓2a期研究积极最终结果","media":"美股速递","content":"<p>Lipella Pharmaceuticals近日宣布，其针对口腔扁平苔藓治疗的候选药物Lp-10的2a期临床研究取得了积极的最终结果。</p>\n<p>该项研究结果的公布标志着公司在开发这一创新疗法方面取得了重要进展。口腔扁平苔藓是一种慢性炎症性疾病，影响口腔黏膜，目前治疗选择有限。</p>\n<p>Lp-10作为Lipella Pharmaceuticals的核心在研产品，此次2a期研究的成功为后续临床开发奠定了坚实基础。公司表示，这一积极结果将推动该候选药物向更大规模的临床试验阶段发展。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lipella Pharmaceuticals公布Lp-10治疗口腔扁平苔藓2a期研究积极最终结果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLipella Pharmaceuticals公布Lp-10治疗口腔扁平苔藓2a期研究积极最终结果\n</h2>\n\n<h4 class=\"meta\">\n\n2025-09-18 20:01 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Lipella Pharmaceuticals近日宣布，其针对口腔扁平苔藓治疗的候选药物Lp-10的2a期临床研究取得了积极的最终结果。\n该项研究结果的公布标志着公司在开发这一创新疗法方面取得了重要进展。口腔扁平苔藓是一种慢性炎症性疾病，影响口腔黏膜，目前治疗选择有限。\nLp-10作为Lipella Pharmaceuticals的核心在研产品，此次2a期研究的成功为后续临床开发奠定了坚实基础。...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LIPO","symbol_name":"Lipella Pharmaceuticals Inc","start_time":0,"source_url":"","article_id":"1124634041","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124634041","pubTimestamp":1758196887,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Lipella Pharmaceuticals近日宣布，其针对口腔扁平苔藓治疗的候选药物Lp-10的2a期临床研究取得了积极的最终结果。\n该项研究结果的公布标志着公司在开发这一创新疗法方面取得了重要进展。口腔扁平苔藓是一种慢性炎症性疾病，影响口腔黏膜，目前治疗选择有限。\nLp-10作为Lipella Pharmaceuticals的核心在研产品，此次2a期研究的成功为后续临床开发奠定了坚实基础。公司表示，这一积极结果将推动该候选药物向更大规模的临床试验阶段发展。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LIPO":"Lipella Pharmaceuticals Inc","BK4139":"生物科技"},"translate_title":"Lipella Pharmaceuticals Announces Positive Final Results of Phase 2a Study of Lp-10 for Oral Lichen Planus","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LIPO":1},"content_text":"Lipella Pharmaceuticals近日宣布，其针对口腔扁平苔藓治疗的候选药物Lp-10的2a期临床研究取得了积极的最终结果。\n该项研究结果的公布标志着公司在开发这一创新疗法方面取得了重要进展。口腔扁平苔藓是一种慢性炎症性疾病，影响口腔黏膜，目前治疗选择有限。\nLp-10作为Lipella Pharmaceuticals的核心在研产品，此次2a期研究的成功为后续临床开发奠定了坚实基础。公司表示，这一积极结果将推动该候选药物向更大规模的临床试验阶段发展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124634041","isCrawlerRequest":true}